IGF1 and obesity due to melanocortin 4 receptor deficiency: The multiplicity of responses orchestrated by this axis supports the evidence that unbalanced IGF activity is associated with several pathologies, including diabetes, growth retardation, neurodegenerative diseases, obesity, osteoporosis, and cancer [4,5].